Default company panoramic image

FluTrends International Corporation

We leverage science to save lives, reduce morbidity and lessen the economic impact of influenza with the intent to eliminate the disease.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Reston, VA, USA
  • Currency USD
  • Employees 4
  • Website

Company Summary

FluTrends is a biotechnology company that plans to develop and commercialize products for the prevention of influenza. FluTrend's approach includes a combination of biotechnology, personal protections and a multi-layered prevention program. The long term goal of the company is to eradicate influenza through new research and the development of a cure.


  • Default avatar
    Dr. Steven Schwartz, M.D., FAAFP
    Founder, Chairman and Chief Medical Officer

    Dr. Steven W. Schwartz, M.D., FAAFP is uniquely qualified to lead FluTrends due to his decades of experience as a family physician as well as the experience of founding and running a healthcare IT company, UniTrends. He graduated Summa Cum Laude from Duke University and attended Duke University School of Medicine. For over twenty years, Dr. Schwartz was a practicing family physician. He is board certified by the American Board of Family Practice.

  • Default avatar
    Bradley Schwartz
    Acting President and CEO

    With more than 30 years of experience in consulting and technology integration, Mr. Schwartz brings to FluTrends his expertise in helming the operations of large and small businesses. As the COO of the $3.5B KPMG with operations in 39 countries, he also oversaw the Health Care consulting unit. At present, he is also the Managing Partner of Blue Canopy, LLC. Mr. Schwartz holds two engineering degrees from Duke University and a Rensselaer MBA.

  • Default avatar
    Christopher Nelson
    Chief Financial Officer

    Mr. Nelson has over two decades of accomplishments in growing successful companies in the Internet and IT industries. Most recently, he founded and developed a company specializing in consumer sales of mobile content using web and viral marketing. Mr. Nelson has also served as CFO of a NASDAQ-listed, publicly traded corporation, where he oversaw the implementation of Sarbanes-Oxley compliance. He has an Engineering degree and a Wharton MBA.

  • Default avatar
    Dr. Lauren Costantini, PhD
    Regulatory Compliance and Product Development Consultant

    Dr. Costantini’s career spans more than 15 years in pharmaceuticals development. She leads pre-clinical, clinical and regulatory development for drugs, Medical Foods, devices and supplements through successful launch and commercialization, playing a key role in licensing, patenting and due-diligence. Prior to joining FluTrends, she held the position of VP, R&D at Sierra Neuropharmaceuticals. She was on the faculty of Harvard Medical School.


  • Default avatar
    Cooley LLP, Reston, Virginia;
    Default avatar
    EKS&H, Denver, Colorado;